[Form 4] Medpace Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Medpace Holdings insider transaction: Susan E. Burwig, Executive Vice President, Operations, reported exercising employee stock options and acquiring 10,000 shares of Medpace Holdings, Inc. (MEDP) on 08/26/2025 at a price of $107.93 per share. After the transaction she beneficially owns 67,500 shares directly. The filing also reports outstanding derivative holdings tied to employee stock options that reference 10,000 underlying shares and show 40,984 derivative securities beneficially owned following the reported activity. The form is signed by an attorney-in-fact on 08/28/2025.

Positive

• Officer increased direct ownership by acquiring 10,000 shares, raising reported beneficial ownership to 67,500 shares.
• Employee option previously vested (vested in full on 02/28/2020), indicating this exercise converted longstanding compensation into stock.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Officer exercised options and increased direct ownership; routine executive equity activity without disclosed unusual terms.

The filing documents an option exercise by an executive-level officer that resulted in acquisition of 10,000 common shares at $107.93 each and an increase in reported direct beneficial ownership to 67,500 shares. The disclosure notes vested option rights and remaining derivative holdings. From a governance perspective, this is a standard insider exercise and reporting of equity-based compensation consistent with Section 16 requirements; the filing does not disclose any atypical transfer restrictions, related-party transactions, or plan amendments.

Securities/Compensation Analyst

TL;DR: Executive option exercise converted compensation into equity; impact appears routine and not materially transformative.

The report shows a cashless or cash exercise (transaction code M) of 10,000 shares at $107.93 per share, with the option vesting noted as having occurred on 02/28/2020. Post-transaction direct ownership is 67,500 shares and reported derivative holdings total 40,984 securities. This transaction converts long-held incentive awards into common stock, aligning executive interests with shareholders. The filing provides no earnings or liquidity detail beyond the exercise price and counts.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BURWIG SUSAN E

(Last) (First) (Middle)

C/O MEDPACE HOLDINGS, INC.

5375 MEDPACE WAY

(Street)

CINCINNATI OH 45227

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec. VP, Operations

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2025		M		10,000	A	$107.93	67,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$107.93	08/26/2025		M			10,000	(1)	02/28/2026	Common Stock	10,000	$0	40,984	D

Explanation of Responses:

1. The option vested in full on February 28, 2020.

Remarks:

	/s/ Stephen P. Ewald, Attorney-in-Fact for Susan E. Burwig	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Susan E. Burwig report on Form 4 for MEDP?

She reported exercising employee stock options to acquire 10,000 shares at $107.93 per share on 08/26/2025 and now beneficially owns 67,500 shares.

How many shares did the reporting person acquire and at what price?

10,000 shares were acquired at $107.93 per share on 08/26/2025.

What is the reporting person’s role at Medpace Holdings (MEDP)?

Susan E. Burwig is Executive Vice President, Operations and is identified as an officer on the Form 4.

Were the options reported as vested and when did they vest?

Yes — the filing states the option vested in full on 02/28/2020.

How many derivative securities remain beneficially owned after the transaction?

The filing reports 40,984 derivative securities beneficially owned following the reported transactions.